Regulators will give it a thorough screening – and its tax implications will become a political football – but the merger of Pfizer Inc. (PFE ) and Allergan plc (AGN ) announced Monday is likely to take place next year.
Get Premium to keep reading
This is a premium article. Please login to your Dividend.com Premium account to access this article.
Login Now
